$1.00
arrow_drop_down2.91%Key Stats | |
---|---|
Open | $1.02 |
Prev. Close | $1.03 |
EPS | -1.44 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $144.23M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 0.96 | 1.05 |
52 Week Range | 0.73 | 2.63 |
Ratios | |
---|---|
EPS | -1.44 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition ... - GlobeNewswire
Top Performing Industry ETFs In June: Software Leads Returns, Chipmakers Attract Most Inflows
Scilex Holding Company Announces Publication in PAIN Journal Regarding Phase 3 Results of the Pivotal Registration Trial of SP-102 (SEMDEXA™) in Lumbosacral Radicular Pain (Sciatica)
Scilex Holding Company Announces 5-Year Term of $100 Million Financing with Royalty-Based Payments and Potential Strategic Transactions with Perigrove and its Portfolio Companies
Scilex Holding Company Announces That Many National Pharmacy Chains and Independent Pharmacies Have Begun Stocking GLOPERBA®